{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T14:17:48Z","timestamp":1793197068836,"version":"4.5.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T00:00:00Z","timestamp":1744156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T00:00:00Z","timestamp":1744156800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004156","name":"Mahidol University","doi-asserted-by":"publisher","award":["RF_64085"],"award-info":[{"award-number":["RF_64085"]}],"id":[{"id":"10.13039\/501100004156","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004156","name":"Mahidol University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004156","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Despite receiving an annual influenza vaccination, lupus patients showed a decline in immunological responses for various reasons. This study aimed to assess immune responses after booster- (BD) and standard-dose (SD) quadrivalent influenza vaccine and the adverse events and incidence of influenza infection among lupus patients. A randomized controlled trial was conducted between March 2021 and May 2022 at Ramathibodi Hospital. All lupus patients were stratified into two groups depending on the depth of immunosuppressive therapy and randomized to receive either BD or SD. Hemagglutination inhibition assay (HAI) before vaccination and 4\u00a0weeks after completion of the vaccination series were assessed. The incidence of influenza infection and vaccine-associated adverse events were recorded. A total of 109 lupus patients completed the HAI analysis. 54\/109 patients were in high- (HI), and 55\/109 were in low-level immunosuppressive (LI) groups. Focusing at the rates to achieve HAI\u2009\u2265\u20091:160, in the LI group, the rates after SD were 85.5% for H1N1, 69.2% for H3N2\/Hongkong, 82.8% for H3N2\/Cambodia, 85.5% for B\/Victoria, and 81.8% for B\/Yamagata. After BD, the HAI titer rates of\u2009\u2265\u20091:160 cut point were increased in all strains, approaching 100%, similar to the HI group. There was one documented influenza infection during the 12-month follow-up period in LI who received SD. No serious adverse events associated with influenza vaccination were recorded. A booster dose of influenza vaccination may provide a higher HAI titer among lupus patients. The booster influenza vaccine regimen was considered safe in the BD group. Thai Clinical Trials Registry: TCTR20230610003.<\/jats:p>","DOI":"10.1007\/s10238-025-01639-6","type":"journal-article","created":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T14:44:27Z","timestamp":1744209867000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["A study of booster dose influenza vaccination responses compared to standard dose in lupus patients: an open-labeled, randomized controlled study"],"prefix":"10.1007","volume":"25","author":[{"given":"Sasicha","family":"Yingyounyong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pintip","family":"Ngamjanyaporn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prapaporn","family":"Pisitkun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kobporn","family":"Boonnak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thanitta","family":"Suangtamai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Supranee","family":"Thongpradit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Porpon","family":"Rotjanapan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,9]]},"reference":[{"key":"1639_CR1","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.ijid.2023.02.002","volume":"129","author":"C Chen","year":"2023","unstructured":"Chen C, Jiang D, Yan D, Pi L, Zhang X, Du Y, Liu X, Yang M, Zhou Y, Ding C, et al. The global region-specific epidemiologic characteristics of influenza: World Health Organization FluNet data from 1996 to 2021. Int J Infect Dis. 2023;129:118\u201324.","journal-title":"Int J Infect Dis"},{"issue":"1","key":"1639_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5144\/0256-4947.59365","volume":"30","author":"S Al Hajjar","year":"2010","unstructured":"Al Hajjar S, McIntosh K. The first influenza pandemic of the 21st century. Ann Saudi Med. 2010;30(1):1\u201310.","journal-title":"Ann Saudi Med"},{"issue":"4","key":"1639_CR3","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1111\/j.1750-2659.2011.00302.x","volume":"6","author":"M Chittaganpitch","year":"2012","unstructured":"Chittaganpitch M, Supawat K, Olsen SJ, Waicharoen S, Patthamadilok S, Yingyong T, Brammer L, Epperson SP, Akrasewi P, Sawanpanyalert P. Influenza viruses in Thailand: 7 years of sentinel surveillance data, 2004\u20132010. Influenza Other Respir Viruses. 2012;6(4):276\u201383.","journal-title":"Influenza Other Respir Viruses"},{"issue":"1","key":"1639_CR4","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3201\/eid1209.05-0979","volume":"12","author":"JK Taubenberger","year":"2006","unstructured":"Taubenberger JK, Morens DM. 1918 Influenza: the mother of all pandemics. Emerg Infect Dis. 2006;12(1):15\u201322.","journal-title":"Emerg Infect Dis"},{"issue":"11","key":"1639_CR5","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.2105\/AJPH.2018.304581","volume":"108","author":"JL Schwartz","year":"2018","unstructured":"Schwartz JL. The Spanish Flu, epidemics, and the turn to biomedical responses. Am J Public Health. 2018;108(11):1455\u20138.","journal-title":"Am J Public Health"},{"issue":"9979","key":"1639_CR6","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1016\/S0140-6736(14)62449-1","volume":"385","author":"J Dobson","year":"2015","unstructured":"Dobson J, Whitley RJ, Pocock S, Monto AS. Oseltamivir treatment for influenza in adults: a meta-analysis of randomised controlled trials. Lancet. 2015;385(9979):1729\u201337.","journal-title":"Lancet"},{"issue":"10","key":"1639_CR7","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1056\/NEJMoa1716197","volume":"379","author":"FG Hayden","year":"2018","unstructured":"Hayden FG, Sugaya N, Hirotsu N, Lee N, de Jong MD, Hurt AC, Ishida T, Sekino H, Yamada K, Portsmouth S, et al. Baloxavir Marboxil for uncomplicated influenza in adults and adolescents. N Engl J Med. 2018;379(10):913\u201323.","journal-title":"N Engl J Med"},{"issue":"1","key":"1639_CR8","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41572-018-0002-y","volume":"4","author":"F Krammer","year":"2018","unstructured":"Krammer F, Smith GJD, Fouchier RAM, Peiris M, Kedzierska K, Doherty PC, Palese P, Shaw ML, Treanor J, Webster RG, et al. Influ Nat Rev Dis Primers. 2018;4(1):3.","journal-title":"Influ Nat Rev Dis Primers"},{"issue":"12","key":"1639_CR9","doi-asserted-by":"publisher","first-page":"e8032","DOI":"10.1371\/journal.pone.0008032","volume":"4","author":"JH Jones","year":"2009","unstructured":"Jones JH, Salathe M. Early assessment of anxiety and behavioral response to novel swine-origin influenza A(H1N1). PLoS ONE. 2009;4(12):e8032.","journal-title":"PLoS ONE"},{"issue":"3","key":"1639_CR10","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1111\/irv.12963","volume":"16","author":"C de Courville","year":"2022","unstructured":"de Courville C, Cadarette SM, Wissinger E, Alvarez FP. The economic burden of influenza among adults aged 18 to 64: A systematic literature review. Influ Other Respir Viruses. 2022;16(3):376\u201385.","journal-title":"Influ Other Respir Viruses"},{"key":"1639_CR11","unstructured":"Kalarikkal SM, Jaishankar GB (2024) Influenza Vaccine. In: StatPearls. edn. Treasure Island (FL)"},{"issue":"5","key":"1639_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr7005a1","volume":"70","author":"LA Grohskopf","year":"2021","unstructured":"Grohskopf LA, Alyanak E, Ferdinands JM, Broder KR, Blanton LH, Talbot HK, Fry AM. Prevention and control of seasonal influenza with vaccines: recommendations of the advisory committee on immunization practices, United States, 2021\u201322 influenza season. MMWR Recomm Rep. 2021;70(5):1\u201328.","journal-title":"MMWR Recomm Rep"},{"issue":"1","key":"1639_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr7101a1","volume":"71","author":"LA Grohskopf","year":"2022","unstructured":"Grohskopf LA, Blanton LH, Ferdinands JM, Chung JR, Broder KR, Talbot HK, Morgan RL, Fry AM. Prevention and control of seasonal influenza with vaccines: recommendations of the advisory committee on immunization practices - United States, 2022\u201323 influenza season. MMWR Recomm Rep. 2022;71(1):1\u201328.","journal-title":"MMWR Recomm Rep"},{"key":"1639_CR14","unstructured":"Tantawichien T (2023) Recommended Adult and Elderly Immunization Schedule"},{"issue":"3","key":"1639_CR15","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1007\/s11739-023-03456-9","volume":"19","author":"R Antonelli Incalzi","year":"2024","unstructured":"Antonelli Incalzi R, Consoli A, Lopalco P, Maggi S, Sesti G, Veronese N, Volpe M. Influenza vaccination for elderly, vulnerable and high-risk subjects: a narrative review and expert opinion. Intern Emerg Med. 2024;19(3):619\u201340.","journal-title":"Intern Emerg Med"},{"issue":"6","key":"1639_CR16","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.3390\/v13061109","volume":"13","author":"KB Wiggins","year":"2021","unstructured":"Wiggins KB, Smith MA, Schultz-Cherry S. The nature of immune responses to influenza vaccination in high-risk populations. Viruses. 2021;13(6):1109.","journal-title":"Viruses"},{"issue":"2","key":"1639_CR17","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1111\/j.1365-2567.2011.03435.x","volume":"133","author":"KA Richards","year":"2011","unstructured":"Richards KA, Chaves FA, Sant AJ. The memory phase of the CD4 T-cell response to influenza virus infection maintains its diverse antigen specificity. Immunology. 2011;133(2):246\u201356.","journal-title":"Immunology"},{"issue":"20","key":"1639_CR18","doi-asserted-by":"publisher","first-page":"3955","DOI":"10.1016\/j.vaccine.2007.02.045","volume":"25","author":"V Baldo","year":"2007","unstructured":"Baldo V, Baldovin T, Floreani A, Carraro AM, Trivello R. Family Medicine Group of P: MF59-adjuvanted influenza vaccine confers superior immunogenicity in adult subjects (18\u201360 years of age) with chronic diseases who are at risk of post-influenza complications. Vaccine. 2007;25(20):3955\u201361.","journal-title":"Vaccine"},{"issue":"5","key":"1639_CR19","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1086\/590434","volume":"198","author":"D Holland","year":"2008","unstructured":"Holland D, Booy R, De Looze F, Eizenberg P, McDonald J, Karrasch J, McKeirnan M, Salem H, Mills G, Reid J, et al. Intradermal influenza vaccine administered using a new microinjection system produces superior immunogenicity in elderly adults: a randomized controlled trial. J Infect Dis. 2008;198(5):650\u20138.","journal-title":"J Infect Dis"},{"issue":"12","key":"1639_CR20","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1093\/cid\/ciad458","volume":"77","author":"LD Thomas","year":"2023","unstructured":"Thomas LD, Batarseh E, Hamdan L, Haddadin Z, Dulek D, Kalams S, Stewart LS, Stahl AL, Rahman H, Amarin JZ, et al. Comparison of two high-dose versus two standard-dose influenza vaccines in adult allogeneic hematopoietic cell transplant recipients. Clin Infect Dis. 2023;77(12):1723\u201332.","journal-title":"Clin Infect Dis"},{"key":"1639_CR21","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12979-020-00181-1","volume":"17","author":"JE McElhaney","year":"2020","unstructured":"McElhaney JE, Verschoor CP, Andrew MK, Haynes L, Kuchel GA, Pawelec G. The immune response to influenza in older humans: beyond immune senescence. Immun Ageing. 2020;17:10.","journal-title":"Immun Ageing"},{"issue":"2","key":"1639_CR22","first-page":"297","volume":"2","author":"PF Yong","year":"2008","unstructured":"Yong PF, D\u2019Cruz DP. Mycophenolate mofetil in the treatment of lupus nephritis. Biologics. 2008;2(2):297\u2013310.","journal-title":"Biologics"},{"issue":"3","key":"1639_CR23","doi-asserted-by":"publisher","first-page":"e44","DOI":"10.1093\/cid\/cit684","volume":"58","author":"LG Rubin","year":"2014","unstructured":"Rubin LG, Levin MJ, Ljungman P, Davies EG, Avery R, Tomblyn M, Bousvaros A, Dhanireddy S, Sung L, Keyserling H, et al. 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. Clin Infect Dis. 2014;58(3):e44-100.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"1639_CR24","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1093\/cid\/ciu257","volume":"59","author":"LG Rubin","year":"2014","unstructured":"Rubin LG, et al. Clin Infect Dis 2014; 58:e44\u2013100. Clin Infect Dis. 2014;59(1):144\u2013144.","journal-title":"Clin Infect Dis"},{"key":"1639_CR25","doi-asserted-by":"publisher","first-page":"289","DOI":"10.3389\/fimmu.2015.00289","volume":"6","author":"AW Kay","year":"2015","unstructured":"Kay AW, Blish CA. Immunogenicity and clinical efficacy of influenza vaccination in pregnancy. Front Immunol. 2015;6:289.","journal-title":"Front Immunol"},{"issue":"4","key":"1639_CR26","doi-asserted-by":"publisher","first-page":"707","DOI":"10.3390\/vaccines2040707","volume":"2","author":"CM Trombetta","year":"2014","unstructured":"Trombetta CM, Perini D, Mather S, Temperton N, Montomoli E. Overview of Serological Techniques for Influenza Vaccine Evaluation: Past. Present Future Vaccines. 2014;2(4):707\u201334.","journal-title":"Present Future Vaccines"},{"issue":"7","key":"1639_CR27","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1111\/jth.13336","volume":"14","author":"C Kearon","year":"2016","unstructured":"Kearon C, Ageno W, Cannegieter SC, Cosmi B, Geersing GJ, Kyrle PA. Subcommittees on control of a, predictive, diagnostic variables in thrombotic d: categorization of patients as having provoked or unprovoked venous thromboembolism: guidance from the SSC of ISTH. J Thromb Haemost. 2016;14(7):1480\u20133.","journal-title":"J Thromb Haemost"},{"issue":"Suppl 5","key":"1639_CR28","first-page":"S195","volume":"89","author":"T Thongngarm","year":"2006","unstructured":"Thongngarm T, Valyasevi AM, Pattanapanyasat K, Udompunturak S. Delayed hypersensitivity skin testing in the Thai adult population. J Med Assoc Thai. 2006;89(Suppl 5):S195-200.","journal-title":"J Med Assoc Thai"},{"issue":"10","key":"1639_CR29","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1093\/rheumatology\/kep200","volume":"48","author":"A Holvast","year":"2009","unstructured":"Holvast A, van Assen S, de Haan A, Huckriede A, Benne CA, Westra J, Palache A, Wilschut J, Kallenberg CG, Bijl M. Effect of a second, booster, influenza vaccination on antibody responses in quiescent systemic lupus erythematosus: an open, prospective, controlled study. Rheumatology. 2009;48(10):1294\u20139.","journal-title":"Rheumatology"},{"key":"1639_CR30","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1471-2288-10-18","volume":"10","author":"L Coudeville","year":"2010","unstructured":"Coudeville L, Bailleux F, Riche B, Megas F, Andre P, Ecochard R. Relationship between haemagglutination-inhibiting antibody titres and clinical protection against influenza: development and application of a bayesian random-effects model. BMC Med Res Methodol. 2010;10:18.","journal-title":"BMC Med Res Methodol"},{"issue":"1","key":"1639_CR31","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1186\/s12879-017-2399-4","volume":"17","author":"M Eichner","year":"2017","unstructured":"Eichner M, Schwehm M, Eichner L, Gerlier L. Direct and indirect effects of influenza vaccination. BMC Infect Dis. 2017;17(1):308.","journal-title":"BMC Infect Dis"},{"issue":"10","key":"1639_CR32","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.3390\/vaccines10101675","volume":"10","author":"GE Calabr\u00f2","year":"2022","unstructured":"Calabr\u00f2 GE, D\u2019Ambrosio F, Fallani E, Ricciardi W. Influenza vaccination assessment according to a value-based health care approach. Vaccines. 2022;10(10):1675. https:\/\/doi.org\/10.3390\/vaccines10101675.","journal-title":"Vaccines"},{"issue":"3","key":"1639_CR33","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1080\/21645515.2017.1321722","volume":"14","author":"V Restivo","year":"2018","unstructured":"Restivo V, Costantino C, Bono S, Maniglia M, Marchese V, Ventura G, Casuccio A, Tramuto F, Vitale F. Influenza vaccine effectiveness among high-risk groups: a systematic literature review and meta-analysis of case-control and cohort studies. Hum Vaccin Immunother. 2018;14(3):724\u201335.","journal-title":"Hum Vaccin Immunother"},{"issue":"8","key":"1639_CR34","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.autrev.2006.12.004","volume":"6","author":"M Abu-Shakra","year":"2007","unstructured":"Abu-Shakra M, Press J, Buskila D, Sukenik S. Influenza vaccination of patients with systemic lupus erythematosus: safety and immunogenecity issues. Autoimmun Rev. 2007;6(8):543\u20136.","journal-title":"Autoimmun Rev"},{"issue":"3","key":"1639_CR35","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1080\/21645515.2017.1338547","volume":"14","author":"MR Castrucci","year":"2018","unstructured":"Castrucci MR. Factors affecting immune responses to the influenza vaccine. Hum Vaccin Immunother. 2018;14(3):637\u201346.","journal-title":"Hum Vaccin Immunother"},{"issue":"8","key":"1639_CR36","doi-asserted-by":"publisher","first-page":"2706","DOI":"10.1080\/21645515.2021.1875761","volume":"17","author":"S Wen","year":"2021","unstructured":"Wen S, Wu Z, Zhong S, Li M, Shu Y. Factors influencing the immunogenicity of influenza vaccines. Hum Vaccin Immunother. 2021;17(8):2706\u201318.","journal-title":"Hum Vaccin Immunother"},{"issue":"8","key":"1639_CR37","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1093\/infdis\/jiab391","volume":"225","author":"J Linnik","year":"2022","unstructured":"Linnik J, Syedbasha M, Kaltenbach HM, Vogt D, Hollenstein Y, Kaufmann L, Cantoni N, Ruosch-Girsberger S, Muller AMS, Schanz U, et al. Association of host factors with antibody response to seasonal influenza vaccination in allogeneic hematopoietic stem cell transplant patients. J Infect Dis. 2022;225(8):1482\u201393.","journal-title":"J Infect Dis"},{"issue":"3","key":"1639_CR38","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1053\/j.ajkd.2022.01.425","volume":"80","author":"HJ Manley","year":"2022","unstructured":"Manley HJ, Lacson EK Jr, Aweh G, Chen Li N, Weiner DE, Miskulin DC, Hsu CM, Kapoian T, Hayney MS, Meyer KB, et al. Seroresponse to inactivated and recombinant influenza vaccines among maintenance hemodialysis patients. Am J Kidney Dis. 2022;80(3):309\u201318.","journal-title":"Am J Kidney Dis"},{"issue":"7","key":"1639_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/14760584.2017.1334554","volume":"16","author":"EA Belongia","year":"2017","unstructured":"Belongia EA, Skowronski DM, McLean HQ, Chambers C, Sundaram ME, De Serres G. Repeated annual influenza vaccination and vaccine effectiveness: review of evidence. Expert Rev Vaccines. 2017;16(7):1\u201314.","journal-title":"Expert Rev Vaccines"},{"key":"1639_CR40","unstructured":"Erik A Karlsson PANM, Katelijn Vandemaele, Julia Fitzner, Aspen Hammond, Vanessa Cozza, Wenqing Zhang, Ann Moen (2021) Review of global influenza circulation, late 2019 to 2020, and the impact of the COVID-19 pandemic on influenza circulation"},{"key":"1639_CR41","unstructured":"https:\/\/www.cms.gov\/medicare\/payment\/part-b-drugs\/vaccine-pricing."}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-025-01639-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-025-01639-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-025-01639-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T06:52:28Z","timestamp":1764917548000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-025-01639-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,9]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1639"],"URL":"https:\/\/doi.org\/10.1007\/s10238-025-01639-6","relation":{},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,9]]},"assertion":[{"value":"13 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was reviewed and approved by the Research Ethics Committee of the Faculty of Medicine, Ramathibodi Hospital, Mahidol University, approval no. MURA2023\/591. All participants provided written informed consent to participate in the study and for the publication of their anonymized case details, according to the WMA Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"109"}}